Wyeth Cold Brand Reformulations Boost Consumer Healthcare Results
This article was originally published in The Tan Sheet
Executive Summary
Total 2007 first-quarter net revenue for Wyeth Consumer Healthcare increased 10 percent to $611 million, primarily due to increased cough and cold product sales as the segment continues to recover from restrictions placed on pseudoephedrine products in 2006, according to the firm